IpaH proteins are E3 ubiquitin ligases delivered by the type III secretion apparatus into host cells upon infection of humans by the Gram-negative pathogen Shigella flexneri. These proteins comprise a variable leucine-rich repeat-containing N-terminal domain and a conserved C-terminal domain harboring an invariant cysteine residue that is crucial for activity. IpaH homologs are encoded by diverse animal and plant pathogens. Here we demonstrate that the IpaH C-terminal domain carries the catalytic activity for ubiquitin transfer and that the N-terminal domain carries the substrate specificity. The structure of the IpaH C-terminal domain, determined to 2.65-Å resolution, represents an all-helical fold bearing no resemblance to previously defined E3 ubiquitin ligases. The conserved and essential cysteine residue lies on a flexible, surface-exposed loop surrounded by conserved acidic residues, two of which are crucial for IpaH activity. NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author ManuscriptType III secretion (T3S) systems are used by numerous Gram-negative pathogenic bacteria to deliver effector proteins into the cells of their human, animal or plant hosts. T3S systems comprise the T3S apparatus (T3SA) that form syringe-like structures that span the bacterial envelope and extend like a needle from the bacterial surface, translocators that transit through the T3SA and form a pore within the target cell membrane, effectors that transit through the T3SA and the pore into the cytosol of host cells, and specific chaperones and transcription regulators for secretion and transcription of these effectors 1,2 . Some effectors target the actin cytoskeleton to promote entry or inhibit phagocytosis of the bacterium, whereas other effectors interfere with the host's innate immune responses 1 .The ubiquitin pathway is a common target of bacterial effectors. This pathway involves one ubiquitin-activating enzyme (E1), a limited number of ubiquitin-conjugating enzymes (E2s) and many ubiquitin-ligating enzymes (E3s). The C-terminal glycine residue of 76-residue ubiquitin is first charged via a thioester linkage onto a cysteine residue of E1 and then transferred to a cysteine residue of an E2. E3s recruit an E2 or a subset of E2s for ubiquitin transfer to specific substrates. Two classes of E3s are differentiated on the basis of their mechanism of action and on sequence or structural similarities. RING (really interesting new gene) and U-box (a modified RING motif) domain-containing E3s act as adaptor-like molecules by bringing a ubiquitinated E2 and the substrate into sufficiently close proximity to promote the ubiquitination of the substrate. In contrast, HECT (homologous to E6-associated protein C terminus) domain-containing E3s possess an essential cysteine residue that acts as an acceptor for the ubiquitin carried by the E2 before its transfer to the substrate. The N-and C-terminal domains of HECT E3s are usually involved in substrate binding and catalytic activity, respectively 3 .Several T3S effector...
NleG homologues constitute the largest family of type 3 effectors delivered by pathogenic E. coli, with fourteen members in the enterohaemorrhagic (EHEC) O157:H7 strain alone. Identified recently as part of the non-LEE-encoded (Nle) effector set, this family remained uncharacterised and shared no sequence homology to other proteins including those of known function. The C-terminal domain of NleG2-3 (residues 90 to 191) is the most conserved region in NleG proteins and was solved by NMR. Structural analysis of this structure revealed the presence of a RING finger/U-box motif. Functional assays demonstrated that NleG2-3 as well as NleG5-1, NleG6-2 and NleG9′ family members exhibited a strong autoubiquitination activity in vitro; a characteristic usually expressed by eukaryotic ubiquitin E3 ligases. When screened for activity against a panel of 30 human E2 enzymes, the NleG2-3 and NleG5-1 homologues showed an identical profile with only UBE2E2, UBE2E3 and UBE2D2 enzymes supporting NleG activity. Fluorescence polarization analysis yielded a binding affinity constant of 56±2 µM for the UBE2D2/NleG5-1 interaction, a value comparable with previous studies on E2/E3 affinities. The UBE2D2 interaction interface on NleG2-3 defined by NMR chemical shift perturbation and mutagenesis was shown to be generally similar to that characterised for human RING finger ubiquitin ligases. The alanine substitutions of UBE2D2 residues Arg5 and Lys63, critical for activation of eukaryotic E3 ligases, also significantly decreased both NleG binding and autoubiquitination activity. These results demonstrate that bacteria-encoded NleG effectors are E3 ubiquitin ligases analogous to RING finger and U-box enzymes in eukaryotes.
Culturing eukaryotic cells has widespread applications in research and industry, including the emerging field of cell-cultured meat production colloquially referred to as cellular agriculture. These applications are often restricted by the high cost of growth medium necessary for cell growth. Mitogenic protein growth factors (GFs) are essential components of growth medium and account for upwards of 90% of the total costs. Here, we present a set of expression constructs and a simplified protocol for recombinant production of functionally active GFs, including FGF-2, IGF-1, PDGF-BB and TGF-β1 in Escherichia coli. Using this expression system, we produced soluble GFs from species including bovine, chicken, and fish. Bioactivity analysis revealed orthologs with improved performance compared to commercially available alternatives. We stimated that the production cost of GFs using our methodology will significantly reduce the cost of cell culture medium, facilitating low-cost protocols tailored for cultured meat production and tissue engineering.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.